Suppression of Autoimmune Retinal Inflammation by an Antiangiogenic Drug
Open Access
- 13 June 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6) , e66219
Abstract
Chronic and recurrent uveitis account for approximately 10% of legal blindness in the western world. Autoimmune uveitis is driven by activated CD4+ T cells that differentiate into effector T helper cells (Th1, Th2, and Th17) which release proinflammatory cytokines that damage the retina. In this study we investigated the effect of the methionine aminopeptidase 2 (MetAP2) inhibitor, Lodamin, on T cell activation and differentiation. MetAp2 is an enzyme which regulates cellular protein synthesis and is highly expressed in T cells. Lodamin was found to suppress T cell receptor (TCR) mediated T cell proliferation and reduced the production of Th1 and Th17 cells. Further, Lodamin suppressed overall inflammation in the mouse model of experimental autoimmune uveitis (EAU) by a six fold. This effect was attributed in part to a reduction in retinal proinflammatory cytokines, down regulation of MetAP2 expression in purified lymph node CD4+ T cells, and a general normalization of the systemic immune reaction.Keywords
This publication has 28 references indexed in Scilit:
- Tocilizumab for the Treatment of Rheumatoid Arthritis and Other Systemic Autoimmune Diseases: Current Perspectives and Future DirectionsInternational Journal of Rheumatology, 2012
- Cytokines in Autoimmune UveitisJournal of Interferon & Cytokine Research, 2011
- Broad Spectrum Antiangiogenic Treatment for Ocular Neovascular DiseasesPLOS ONE, 2010
- Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressorBlood, 2010
- Th1 and Th17 cellsAnnals of the New York Academy of Sciences, 2010
- Involution of Collagen-Induced Arthritis with an Angiogenesis Inhibitor, PPI-2458The Journal of Pharmacology and Experimental Therapeutics, 2009
- An orally delivered small-molecule formulation with antiangiogenic and anticancer activityNature Biotechnology, 2008
- Mouse Models of Experimental Autoimmune UveitisOphthalmic Research, 2008
- TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1Nature Medicine, 2007
- TH-17 cells in the circle of immunity and autoimmunityNature Immunology, 2007